Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | ECE1 | P42892 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.34 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11129 | 0.81 | ANPEP (0.55) | KMT2ACYP2C19CYP2D6CYP2C9CYP1A2 | |
| SCHEMBL12131751 | 0.80 | USP2 (0.55) | KMT2ACYP2C19CYP2D6CYP2C9CYP1A2 | |
| SCHEMBL20687626 | 0.79 | ALDH1A1 (0.50) | KMT2ACYP2C19CYP2D6CYP2C9CHRNB2 | |
| SCHEMBL23733367 | 0.79 | KDM4E (0.48) | CHRNB2CHRNB4CHRNA4MAPK1ANPEP | |
| SCHEMBL16297552 | 0.79 | KDM4E (0.48) | CHRNB2CHRNB4CHRNA4MAPK1ANPEP | |
| SCHEMBL21214819 | 0.77 | KMT2A (0.42) | KMT2ACYP2C19CYP2D6CYP2C9CHRNB2 | |
| SCHEMBL21214691 | 0.77 | KMT2A (0.42) | KMT2ACYP2C19CYP2D6CYP2C9CHRNB2 | |
| SCHEMBL15730425 | 0.76 | CYP2C19 (0.37) | KMT2ACYP2C19CYP2D6CYP2C9CYP1A2 | |
| SCHEMBL20810611 | 0.76 | USP2 (0.46) | KMT2ACYP2C19CYP2D6CYP2C9CHRNB2 | |
| SCHEMBL22548464 | 0.76 | USP2 (0.46) | KMT2ACYP2C19CYP2D6CYP2C9CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827621-B2 | Inhibitors of (α-v)(β-6) integrin | MORPHIC THERAPEUTIC, INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-20210276975-A1 | INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN | MORPHIC THERAPEUTIC, INC. | 2021-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210276975-A1 | INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN | ITGB6, ITGA6, ITGAV | KMT2A 3926/4885CYP2C19 4556/4885CYP2D6 1294/4885 |
| US-11827621-B2 | Inhibitors of (α-v)(β-6) integrin | ITGB6, ITGA6, ITGAV | KMT2A 4013/4885CYP2C19 4628/4885CYP2D6 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.